Latest News for: globin

Edit

Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the ...

Victoria Advocate 26 Jun 2025
Initiation follows successful IND clearance based on preclinical data package indicating robust increase in fetal hemoglobin with no cytotoxicity ....
Edit

Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease

PR Newswire 26 Jun 2025
Novel Globin-Switching mechanism derived from Cellarity's AI-powered transcriptomic discovery platform ... a first-in-class Globin-Switching oral medicine designed to treat sickle cell disease (SCD).
  • 1

Article Search

tools
×
×
×
×